These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11561793)

  • 21. Ocular Cicatricial Pemphigoid in Young Patients.
    Jinagal J; Gupta B; Hanumanthu V; Chatterjee D; Limbu S; Malhotra C; Gupta A; Jain AK; Yangzes S; Mahajan R; Handa S; Pandav SS; De D
    Cornea; 2024 Aug; 43(8):1015-1021. PubMed ID: 38692674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
    Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
    Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics and Outcomes of Ocular Cicatricial Pemphigoid: A Cohort Study and Literature Review.
    Fremont F; Pelissier-Suarez C; Fournié P; Porterie M; Thevenin A; Astudillo L; Paricaud K; Gualino V; Soler V; Pugnet G
    Cornea; 2019 Nov; 38(11):1406-1411. PubMed ID: 31356420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical tacrolimus for oral cicatricial pemphigoid.
    Assmann T; Becker J; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2004 Nov; 29(6):674-6. PubMed ID: 15550151
    [No Abstract]   [Full Text] [Related]  

  • 25. Ocular cicatricial pemphigoid.
    Sanfilippo P; Lee G
    Clin Exp Optom; 2003 Jan; 86(1):47-50. PubMed ID: 12568651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I
    Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
    Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
    Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure ocular cicatricial pemphigoid. A distinct immunopathologic subset of cicatricial pemphigoid.
    Hoang-Xuan T; Robin H; Demers PE; Heller M; Toutblanc M; Dubertret L; Prost C
    Ophthalmology; 1999 Feb; 106(2):355-61. PubMed ID: 9951490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients.
    Friedman J; Marcovich AL; Kleinmann G; Schattner A
    Cornea; 2014 Oct; 33(10):1066-70. PubMed ID: 25014147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid.
    Neumann R; Tauber J; Foster CS
    Ophthalmology; 1991 Jun; 98(6):858-62. PubMed ID: 1866137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular cicatricial pemphigoid.
    Hingorani M; Lightman S
    Curr Opin Allergy Clin Immunol; 2006 Oct; 6(5):373-8. PubMed ID: 16954792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of mucous membrane pemphigoid with tacrolimus.
    Suresh L; Martinez Calixto LE; Radfar L
    Spec Care Dentist; 2006; 26(2):66-70. PubMed ID: 16681241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
    Foster CS; Ahmed AR
    Ophthalmology; 1999 Nov; 106(11):2136-43. PubMed ID: 10571350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy.
    Ma L; You C; Hernandez M; Maleki A; Lasave A; Schmidt A; Stephenson A; Zhao T; Anesi S; Foster CS
    Ocul Immunol Inflamm; 2019; 27(4):636-642. PubMed ID: 29517945
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics of patients with ocular cicatricial pemphigoid referred to major tertiary hospital.
    Goldich Y; Ziai S; Artornsombudh P; Avni-Zauberman N; Elbaz U; Rootman DS; Chan CC
    Can J Ophthalmol; 2015 Apr; 50(2):137-42. PubMed ID: 25863854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic chemotherapy for ocular cicatricial pemphigoid.
    Tauber J; Sainz de la Maza M; Foster CS
    Cornea; 1991 May; 10(3):185-95. PubMed ID: 2055022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
    Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
    Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
    [No Abstract]   [Full Text] [Related]  

  • 38. Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid.
    Bhol K; Mohimen A; Neumann R; Yunis J; Foster S; Yunis EJ; Ahmed AR
    Curr Eye Res; 1996 May; 15(5):521-32. PubMed ID: 8670753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Systemic treatment of ocular cicatricial pemphigoid].
    Juri MC; Fernández Romero DS; Devoto MH; Georgiett D; Zárate JO; Malbrán A
    Medicina (B Aires); 2012; 72(2):103-8. PubMed ID: 22522849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.